Vaxil Bio Ltd. Opens the Market

TORONTO, March 21, 2016 /CNW/ - Isaac Maresky, Executive Director, Vaxil Bio Ltd. (VXL), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. Vaxil Bio Ltd. is an Israeli biotech company focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil Bio Ltd. commenced trading on TSX Venture Exchange on March 10, 2016. For more information please visit www.vxlbio.com.

SOURCE TMX Group Limited

Image with caption: "Isaac Maresky, Executive Director, Vaxil Bio Ltd. (VXL), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. Vaxil Bio Ltd. is an Israeli biotech company focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil Bio Ltd. commenced trading on TSX Venture Exchange on March 10, 2016. For more information please visit www.vxlbio.com. (CNW Group/TMX Group Limited)". Image available at: http://photos.newswire.ca/images/download/20160321_C5493_PHOTO_EN_647025.jpg

For further information: For more information please visit www.vxlbio.com.


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890